Cargando…
Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study
The novel coronavirus disease 2019 (COVID-19) pandemic has caused a massive health crisis worldwide and upended the global economy. However, vaccines and traditional drug discovery for COVID-19 cost too much in terms of time, manpower, and money. Drug repurposing becomes one of the promising treatme...
Autores principales: | Meng, Yajie, Jin, Min, Tang, Xianfang, Xu, Junlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825831/ https://www.ncbi.nlm.nih.gov/pubmed/33519322 http://dx.doi.org/10.1016/j.asoc.2021.107135 |
Ejemplares similares
-
Computational drug repositioning using similarity constrained weight regularization matrix factorization: A case of COVID‐19
por: Xu, Junlin, et al.
Publicado: (2022) -
Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19
por: Tang, Xianfang, et al.
Publicado: (2021) -
Drug repositioning based on weighted local information augmented graph neural network
por: Meng, Yajie, et al.
Publicado: (2023) -
Drug repositioning for SARS-CoV-2 by Gaussian kernel similarity bilinear matrix factorization
por: Wang, Yibai, et al.
Publicado: (2022) -
Predicting drug-disease associations by using similarity constrained matrix factorization
por: Zhang, Wen, et al.
Publicado: (2018)